Crinetics Pharmaceuticals, Inc.CRNXNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-9259.19%
↑ 46% vs avg
Percentile
P33
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
-17153.23%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | -9259.19% | +71.4% |
| 2024 | -32345.43% | -486.0% |
| 2023 | -5519.81% | -56.7% |
| 2022 | -3523.31% | +64.4% |
| 2021 | -9905.38% | +90.5% |
| 2020 | -104232.39% | -2421.8% |
| 2019 | -4133.19% | -255.4% |
| 2018 | -1163.06% | -164.3% |
| 2017 | -440.05% | +56.5% |
| 2016 | -1010.53% | - |